Kerala Ayurveda Ltd.
| BSE: 530163 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE817B01025 |
| BSE 00:00 | 14 May | 52.65 |
-0.90 (-1.68%) |
OPEN
53.55 |
HIGH
54.00 |
LOW
52.30 |
| NSE 05:30 | 01 Jan | Kerala Ayurveda Ltd |
| OPEN | 53.55 |
| PREVIOUS CLOSE | 53.55 |
| VOLUME | 5038 |
| 52-Week high | 82.70 |
| 52-Week low | 42.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 56 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Kerala Ayurveda Ltd. (KERALAAYURVEDA) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 691.10 | -1.64 | 721.90 | 434.25 | 165815.62 |
| Divi's Lab. | 4022.00 | -0.97 | 4203.00 | 2094.60 | 106763.99 |
| Dr Reddy's Labs | 5195.85 | -2.00 | 5514.65 | 3613.45 | 86406.99 |
| Cipla | 904.10 | 0.60 | 966.00 | 565.90 | 72911.14 |
| Cadila Health. | 617.10 | -4.61 | 673.70 | 321.30 | 63172.53 |
| Aurobindo Pharma | 1006.60 | -0.95 | 1063.75 | 655.00 | 58976.69 |
| Lupin | 1178.80 | -2.64 | 1246.30 | 828.65 | 53488.05 |
| Gland Pharma | 2882.10 | 0.82 | 2982.00 | 1701.00 | 47237.62 |
| Biocon | 388.95 | 0.92 | 487.70 | 320.90 | 46697.34 |
| Torrent Pharma. | 2722.50 | -0.12 | 3040.00 | 2232.00 | 46070.15 |
| Apollo Hospitals | 3139.65 | -1.78 | 3396.00 | 1253.25 | 45141.89 |
| Piramal Enterp. | 1633.00 | -3.64 | 2008.20 | 845.90 | 36832.32 |
| Alkem Lab | 2995.05 | 0.01 | 3150.00 | 2223.55 | 35805.82 |
| Abbott India | 16098.30 | -0.10 | 18310.35 | 13970.10 | 34208.89 |
| Ipca Labs. | 2148.35 | 0.55 | 2455.55 | 1467.00 | 27251.82 |
| Glaxosmi. Pharma | 1503.80 | 1.65 | 1805.00 | 1258.00 | 25475.88 |
| Laurus Labs | 468.25 | -3.31 | 504.15 | 84.40 | 25126.29 |
| Pfizer | 5278.95 | -1.29 | 5875.00 | 3940.00 | 24151.20 |
| Dr Lal Pathlabs | 2721.45 | -1.76 | 3398.95 | 1500.00 | 22680.56 |
| Syngene Intl. | 566.90 | -2.81 | 644.65 | 319.00 | 22676.00 |
Quick Links for Kerala Ayurveda:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
